Yellow fever vaccine
- PMID: 16117712
- DOI: 10.1586/14760584.4.4.553
Yellow fever vaccine
Abstract
Yellow fever, a mosquito-borne viral hemorrhagic fever, is one of the most lethal diseases of humankind. The etiologic agent is the prototype member of the genus Flavivirus, family Flaviviridae, a group of small, enveloped, positive-sense, single-strand RNA viruses. Approximately one in seven people who become infected develop a rapidly progressive illness, with hepatitis, renal failure, hemorrhage and cardiovascular shock, with a case fatality rate of 20-50%. Yellow fever occurs in sub-Saharan Africa and tropical South America, where it remains a continuing public health problem of varying magnitude, depending on the level of vaccination coverage in the human population and cyclical, ecologic and climatic factors that influence virus transmission.
Similar articles
-
[Yellow fever].Przegl Epidemiol. 2004;58 Suppl 1:101-5. Przegl Epidemiol. 2004. PMID: 15807166 Review. Polish.
-
[Yellow fever--a tropical danger].MMW Fortschr Med. 2004 Aug 5;146(31-32):36-7. MMW Fortschr Med. 2004. PMID: 15529706 German.
-
Yellow fever vaccines and international travelers.Expert Rev Vaccines. 2008 Jul;7(5):579-87. doi: 10.1586/14760584.7.5.579. Expert Rev Vaccines. 2008. PMID: 18564013 Review.
-
Prevention of yellow fever in persons traveling to the tropics.Clin Infect Dis. 2002 May 15;34(10):1369-78. doi: 10.1086/340104. Epub 2002 Apr 25. Clin Infect Dis. 2002. PMID: 11981733 Review.
-
An inactivated cell-culture vaccine against yellow fever.N Engl J Med. 2011 Apr 7;364(14):1326-33. doi: 10.1056/NEJMoa1009303. N Engl J Med. 2011. PMID: 21470010 Clinical Trial.
Cited by
-
Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine.NPJ Vaccines. 2021 Apr 26;6(1):64. doi: 10.1038/s41541-021-00318-3. NPJ Vaccines. 2021. PMID: 33903598 Free PMC article.
-
CD8+ T cells complement antibodies in protecting against yellow fever virus.J Immunol. 2015 Feb 1;194(3):1141-53. doi: 10.4049/jimmunol.1402605. Epub 2014 Dec 24. J Immunol. 2015. PMID: 25539816 Free PMC article.
-
Can Modern Molecular Modeling Methods Help Find the Area of Potential Vulnerability of Flaviviruses?Int J Mol Sci. 2022 Jul 13;23(14):7721. doi: 10.3390/ijms23147721. Int J Mol Sci. 2022. PMID: 35887069 Free PMC article.
-
The impact of transcriptomics on the fight against tuberculosis: focus on biomarkers, BCG vaccination, and immunotherapy.Clin Dev Immunol. 2011;2011:192630. doi: 10.1155/2011/192630. Epub 2010 Dec 20. Clin Dev Immunol. 2011. PMID: 21197423 Free PMC article. Review.
-
Synergistic Internal Ribosome Entry Site/MicroRNA-Based Approach for Flavivirus Attenuation and Live Vaccine Development.mBio. 2017 Apr 18;8(2):e02326-16. doi: 10.1128/mBio.02326-16. mBio. 2017. PMID: 28420742 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical